EP 1259260 A1 20021127 - COMBINATION THERAPY FOR THE TREATMENT OF INFLAMMATORY AND RESPIRATORY DISEASES
Title (en)
COMBINATION THERAPY FOR THE TREATMENT OF INFLAMMATORY AND RESPIRATORY DISEASES
Title (de)
KOMBINATIONSTHERAPIE ZUR BEHANDLUNG ENTZÜNDLICHER UND RESPIRATORISCHER ERKRANKUNGEN
Title (fr)
THERAPIE COMBINEE DESTINEE AU TRAITEMENT DE MALADIES INFLAMMATOIRES ET RESPIRATOIRES
Publication
Application
Priority
- US 0034262 W 20001222
- US 17472300 P 20000106
Abstract (en)
[origin: WO0149323A1] A pharmaceutical composition for the treatment of Inflammatory Disease or Respiratory Disease in mammals, which comprises, as active ingredients, a neutrophil elastase inhibitor and an sPLA2 inhibitor.
IPC 1-7
IPC 8 full level
A61K 31/197 (2006.01); A61K 31/198 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 45/06 (2006.01); A61P 1/00 (2006.01); A61P 1/18 (2006.01); A61P 7/00 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 21/00 (2006.01); A61P 29/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR)
A61K 31/404 (2013.01 - KR); A61K 45/06 (2013.01 - EP); A61P 1/00 (2017.12 - EP); A61P 1/18 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/06 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 0149323A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0149323 A1 20010712; AU 2728301 A 20010716; EP 1259260 A1 20021127; JP 2003519198 A 20030617; KR 20030016214 A 20030226
DOCDB simple family (application)
US 0034262 W 20001222; AU 2728301 A 20001222; EP 00990230 A 20001222; JP 2001549689 A 20001222; KR 20027008752 A 20020705